The novel approach of this peptide represents a exciting advance in the handling of the condition. Distinct from existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide010106.blogchaat.com/42309115/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment